Sven Klebs

643 total citations
27 papers, 461 citations indexed

About

Sven Klebs is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sven Klebs has authored 27 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sven Klebs's work include Blood Pressure and Hypertension Studies (13 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Heart Failure Treatment and Management (7 papers). Sven Klebs is often cited by papers focused on Blood Pressure and Hypertension Studies (13 papers), Cardiovascular Syncope and Autonomic Disorders (7 papers) and Heart Failure Treatment and Management (7 papers). Sven Klebs collaborates with scholars based in Germany, Switzerland and United Kingdom. Sven Klebs's co-authors include Renate Handrock, Stefan Störk, Raquel Lahoz, Jochen Walker, Josephine Jacob, Rolf Wachter, Ulrich Laufs, Raymond G. Schlienger, Bogdan Balas and Torsten Zuberbier and has published in prestigious journals such as European Heart Journal, Journal of Immunological Methods and Atherosclerosis.

In The Last Decade

Sven Klebs

26 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Klebs Germany 12 339 85 84 47 45 27 461
Ines Potočnjak Croatia 11 133 0.4× 60 0.7× 60 0.7× 38 0.8× 53 1.2× 34 390
Margarita Capel Spain 11 100 0.3× 67 0.8× 32 0.4× 62 1.3× 11 0.2× 44 265
Rodney S. Badger United States 8 268 0.8× 21 0.2× 177 2.1× 72 1.5× 12 0.3× 14 450
Mattias Brunström Sweden 9 463 1.4× 180 2.1× 84 1.0× 15 0.3× 13 0.3× 34 656
W. März Germany 8 71 0.2× 44 0.5× 67 0.8× 42 0.9× 3 0.1× 19 301
Pooja Dewan United Kingdom 12 504 1.5× 175 2.1× 74 0.9× 109 2.3× 24 0.5× 22 658
Michael Dall Denmark 8 261 0.8× 31 0.4× 185 2.2× 91 1.9× 3 0.1× 12 511
Alberto Calderón Spain 15 595 1.8× 92 1.1× 66 0.8× 10 0.2× 17 0.4× 41 644
C. Shaun Wagner United States 8 259 0.8× 99 1.2× 45 0.5× 103 2.2× 26 0.6× 12 400
Guido Garavelli Italy 14 357 1.1× 165 1.9× 93 1.1× 38 0.8× 8 0.2× 23 640

Countries citing papers authored by Sven Klebs

Since Specialization
Citations

This map shows the geographic impact of Sven Klebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Klebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Klebs more than expected).

Fields of papers citing papers by Sven Klebs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Klebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Klebs. The network helps show where Sven Klebs may publish in the future.

Co-authorship network of co-authors of Sven Klebs

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Klebs. A scholar is included among the top collaborators of Sven Klebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Klebs. Sven Klebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klebs, Sven, et al.. (2024). Epidemiology of Paediatric Chronic Heart Failure in Germany—A Population-Based Analysis. ESC Heart Failure. 11(6). 4371–4380. 3 indexed citations
2.
3.
Laufs, Ulrich, et al.. (2021). Characteristics of patients with a lipoprotein(a) assessment – a health insurance claims database analysis. European Heart Journal. 42(Supplement_1).
4.
Wachter, Rolf, Sanjiv J. Shah, Martín Cowie, et al.. (2020). Angiotensin Receptor Neprilysin Inhibition versus Individualized RAAS Blockade: Design and Rationale of the PARALLAX Trial. ESC Heart Failure. 7(3). 856–864. 29 indexed citations
5.
6.
Wachter, Rolf, et al.. (2019). Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany. European Journal of Heart Failure. 21(5). 588–597. 43 indexed citations
7.
Wachter, Rolf, Sven Klebs, Matthias Schindler, et al.. (2018). Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany. Postgraduate Medicine. 130(3). 308–316. 19 indexed citations
8.
Störk, Stefan, Renate Handrock, Josephine Jacob, et al.. (2017). Epidemiology of heart failure in Germany: a retrospective database study. Clinical Research in Cardiology. 106(11). 913–922. 86 indexed citations
9.
Störk, Stefan, Renate Handrock, Josephine Jacob, et al.. (2017). Treatment of chronic heart failure in Germany: a retrospective database study. Clinical Research in Cardiology. 106(11). 923–932. 25 indexed citations
10.
11.
Eckert, Siegfried, et al.. (2013). Meta-analysis of three observational studies of amlodipine/valsartan in hypertensive patients with additional risk factors. Blood Pressure. 22(sup1). 11–21. 9 indexed citations
12.
13.
Düsing, Rainer, Renate Handrock, Sven Klebs, Eric Tousset, & Bernard Vrijens. (2009). Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. Journal of Hypertension. 27(4). 894–901. 24 indexed citations
14.
15.
Menne, Jan, Csaba Farsang, Sven Klebs, et al.. (2008). Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial. Journal of Hypertension. 26(9). 1860–1867. 36 indexed citations
16.
17.
Schweizer, Johannes, et al.. (2007). Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination. Current Medical Research and Opinion. 23(11). 2877–2885. 19 indexed citations
18.
Weidinger, Gottfried, et al.. (2005). Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other angiotensin-receptor blockers. Advances in Therapy. 22(3). 263–277. 7 indexed citations
19.
Klebs, Sven, et al.. (2003). Detection of H-2 alleles by PCR-RFLP—an alternative to flow cytometry in the screening of transgenic mice. Journal of Immunological Methods. 276(1-2). 197–205. 1 indexed citations
20.
Ellerkamp, Verena, Thomas J. Musholt, Sven Klebs, et al.. (2000). A murine model of allogeneic adrenocortical cell transplantation: Perspectives for the treatment of Addison's disease in humans. Surgery. 128(6). 999–1006. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ines Potočnjak Breakdown of academic impact, for papers by Margarita Capel Breakdown of academic impact, for papers by Rodney S. Badger Breakdown of academic impact, for papers by Mattias Brunström Breakdown of academic impact, for papers by W. März Breakdown of academic impact, for papers by Pooja Dewan Breakdown of academic impact, for papers by Michael Dall Breakdown of academic impact, for papers by Alberto Calderón Breakdown of academic impact, for papers by C. Shaun Wagner Breakdown of academic impact, for papers by Guido Garavelli
Rankless by CCL
2026